Establishment of Biomarker Panel For Forecasting Chronic Graft-Versus-Host Disease (cGVHD) After Allo-HSCT

NCT07539220 · clinicaltrials.gov ↗
NA
Phase
NOT_YET_RECRUITING
Status
1500
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Institute of Hematology & Blood Diseases Hospital, China